{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:28:21Z","timestamp":1790692101224,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":137,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI19\/00970 a PS-C"],"award-info":[{"award-number":["PI19\/00970 a PS-C"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["S2017\/BMD-3673"],"award-info":[{"award-number":["S2017\/BMD-3673"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.nefroe.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T07:58:08Z","timestamp":1663833488000},"page":"280-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contribution of functional and quantitative genetic variants of Complement Factor H and Factor H-Related (FHR) proteins on renal pathology"],"prefix":"10.1016","volume":"42","author":[{"given":"Irene","family":"G\u00f3mez Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"S\u00e1nchez-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2022.09.002_bib0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0010","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.15252\/embj.201591881","article-title":"Complement activation, regulation, and molecular basis for complement-related diseases","volume":"34","author":"Bajic","year":"2015","journal-title":"EMBO J."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/imr.12475","article-title":"Protection of host cells by complement regulators","volume":"274","author":"Schmidt","year":"2016","journal-title":"Immunol Rev."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ackd.2012.02.015","article-title":"Complement in glomerular disease","volume":"19","author":"Vernon","year":"2012","journal-title":"Adv Chronic Kidney Dis."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.molimm.2018.06.011","article-title":"Common and rare genetic variants of complement components in human disease","volume":"102","author":"Goicoechea de Jorge","year":"2018","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0030","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1002\/1873-3468.12284","article-title":"Self-nonself discrimination by the complement system","volume":"590","author":"Meri","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0035","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4049\/jimmunol.1801545","article-title":"Self versus nonself discrimination by the soluble complement regulators factor H and FHL-1","volume":"202","author":"Dopler","year":"2019","journal-title":"J Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2004.02.005","article-title":"The human complement factor H: functional roles, genetic variations and disease associations","volume":"41","author":"Rodr\u00edguez de C\u00f3rdoba","year":"2004","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0045","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.it.2015.04.008","article-title":"Factor H-related proteins determine complement-activating surfaces","volume":"36","author":"J\u00f3zsi","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.660194","article-title":"A family affair: addressing the challenges of factor H and the related proteins","volume":"12","author":"Poppelaars","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0055","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","article-title":"Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation","volume":"114","author":"Heinen","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0060","doi-asserted-by":"crossref","first-page":"e78617","DOI":"10.1371\/journal.pone.0078617","article-title":"Human factor H-related protein 2 (CFHR2) regulates complement activation","volume":"8","author":"Eberhardt","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0065","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molimm.2008.10.029","article-title":"Human complement factor H-related protein 4 binds and recruits native pentameric C-reactive protein to necrotic cells","volume":"46","author":"Mihlan","year":"2009","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0070","doi-asserted-by":"crossref","first-page":"19528","DOI":"10.1074\/jbc.M112.364471","article-title":"Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein","volume":"287","author":"Hebecker","year":"2012","journal-title":"J Biol Chem."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0075","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.4049\/jimmunol.1403121","article-title":"Factor H-related protein 5 interacts with pentraxin 3 and the extracellular matrix and modulates complement activation","volume":"194","author":"Csincsi","year":"2015","journal-title":"J Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4049\/jimmunol.1600483","article-title":"FHR-1 binds to C-reactive protein and enhances rather than inhibits complement activation","volume":"199","author":"Csincsi","year":"2017","journal-title":"J Immunol."},{"issue":"Mar 2","key":"10.1016\/j.nefroe.2022.09.002_bib0085","article-title":"The molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases","author":"Martin Merinero","year":"2021","journal-title":"Blood."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3389\/fimmu.2018.01607","article-title":"Self-damage caused by dysregulation of the complement alternative pathway: relevance of the factor H protein family","volume":"9","author":"S\u00e1nchez-Corral","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1681\/ASN.2019050515","article-title":"CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy","volume":"31","author":"Zipfel","year":"2020","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0100","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1681\/ASN.2015010012","article-title":"Rare variants in the complement factor H-related protein 5 gene contribute to genetic susceptibility to IgA nephropathy","volume":"27","author":"Zhai","year":"2016","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0105","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.kint.2017.03.041","article-title":"Elevated factor H-related protein 1 and factor H pathogenic variants decrease complement regulation in IgA nephropathy","volume":"92","author":"Tortajada","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0110","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","article-title":"Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome","volume":"3","author":"Zipfel","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ng.787","article-title":"Genome-wide association study identifies susceptibility loci for IgA nephropathy","volume":"43","author":"Gharavi","year":"2011","journal-title":"Nat Genet."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2007.03552.x","article-title":"Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H","volume":"151","author":"de C\u00f3rdoba","year":"2008","journal-title":"Clin Exp Immunol."},{"issue":"2 Pt B","key":"10.1016\/j.nefroe.2022.09.002_bib0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molimm.2015.06.021","article-title":"Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome","volume":"67","author":"Bernab\u00e9u-Herrero","year":"2015","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0130","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2009-05-223834","article-title":"Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome","volume":"114","author":"Abarrategui-Garrido","year":"2009","journal-title":"Blood."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0135","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fimmu.2018.00848","article-title":"High complement factor H-related (FHR)-3 levels are associated with the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B","volume":"9","author":"Pouw","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molimm.2017.06.170","article-title":"Quantitative Western-blot profiles of factor H and factor H-related proteins in atypical haemolytic uraemic syndrome and C3 glomerulopathy","volume":"89","author":"G\u00f3mez","year":"2017","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0145","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jmg.2005.038315","article-title":"Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)","volume":"43","author":"Abrera-Abeleda","year":"2006","journal-title":"J Med Genet."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00251-004-0660-7","article-title":"Genetic and environmental factors influencing the human factor H plasma levels","volume":"56","author":"Esparza-Gordillo","year":"2004","journal-title":"Immunogenetics."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0155","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1167\/iovs.07-1523","article-title":"Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration","volume":"49","author":"Hakobyan","year":"2008","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0160","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1093\/hmg\/ddt336","article-title":"Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration","volume":"22","author":"Ansari","year":"2013","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152164","article-title":"Complement factor H-related protein 3 serum levels are low compared to factor H and mainly determined by gene copy number variation in CFHR3","volume":"11","author":"Pouw","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0170","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.kint.2017.03.043","article-title":"Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy","volume":"92","author":"Medjeral-Thomas","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41467-020-14499-3","article-title":"Increased circulating levels of factor H-related protein 4 are strongly associated with age-related macular degeneration","volume":"11","author":"Cipriani","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0180","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3389\/fimmu.2018.01727","article-title":"Reference intervals of factor H and factor H-related proteins in healthy children","volume":"9","author":"van Beek","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0185","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/sji.12154","article-title":"Complement profile in neonates of different gestational ages","volume":"79","author":"Grumach","year":"2014","journal-title":"Scand J Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2249.2000.01285.x","article-title":"Different regulation of factor H and FHL-1\/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)","volume":"121","author":"Friese","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0195","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in vivo","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0200","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3389\/fimmu.2017.01328","article-title":"Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 circulates only as homodimer in human plasma","volume":"8","author":"van Beek","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060352","article-title":"Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32","volume":"8","author":"Holmes","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.ejhg.5201324","article-title":"FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene","volume":"13","author":"J\u00f3zsi","year":"2005","journal-title":"Eur J Hum Genet."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0215","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3389\/fimmu.2018.00729","article-title":"Complement factor H-related protein 4A is the dominant circulating splice variant of CFHR4","volume":"9","author":"Brouwer","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2012.02.329","article-title":"Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency","volume":"60","author":"Vernon","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0225","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.kint.2018.02.023","article-title":"Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy","volume":"94","author":"Zhu","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0230","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1681\/ASN.2014010096","article-title":"Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy","volume":"26","author":"Zhu","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0235","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ekir.2020.11.019","article-title":"Glomerular complement factor H-related protein 5 is associated with histologic injury in immunoglobulin a nephropathy","volume":"6","author":"Guo","year":"2020","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.641656","article-title":"Complement genetic variants and FH Desialylation in S. pneumoniae-Haemolytic Uraemic Syndrome","volume":"12","author":"G\u00f3mez Delgado","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0245","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molimm.2014.07.004","article-title":"Complement nomenclature 2014","volume":"61","author":"Kemper","year":"2014","journal-title":"Mol Immunol."},{"key":"10.1016\/j.nefroe.2022.09.002_bib0250","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fimmu.2019.01308","article-title":"Complement nomenclature-deconvoluted","volume":"10","author":"Bohlson","year":"2019","journal-title":"Front Immunol."}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142200092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142200092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:48:08Z","timestamp":1761853688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S201325142200092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S201325142200092X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2022.09.002","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of functional and quantitative genetic variants of Complement Factor H and Factor H-Related (FHR) proteins on renal pathology","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2021.07.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}